Witnessing the stock’s movement on the chart, on Wednesday, Mereo Biopharma Group Plc ADR (NASDAQ: MREO) set off with pace as it heaved 0.85% to $2.37, before settling in for the price of $2.35 at the close. Taking a more long-term approach, MREO posted a 52-week range of $2.25-$5.02.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of -25.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 41.78%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 35.71%. This publicly-traded company’s shares outstanding now amounts to $154.73 million, simultaneously with a float of $142.29 million. The organization now has a market capitalization sitting at $366.71 million. At the time of writing, stock’s 50-day Moving Average stood at $2.75.
Mereo Biopharma Group Plc ADR (MREO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Mereo Biopharma Group Plc ADR’s current insider ownership accounts for 8.04%, in contrast to 66.45% institutional ownership. According to the most recent insider trade that took place on Sep 13 ’24, this organization’s Chief Executive Officer sold 60,046 shares at the rate of 4.22, making the entire transaction reach 253,454 in total value, affecting insider ownership by 808,921. Preceding that transaction, on Sep 12 ’24, Company’s Chief Executive Officer sold 28,611 for 4.47, making the whole transaction’s value amount to 127,968. This particular insider is now the holder of 868,967 in total.
Mereo Biopharma Group Plc ADR (MREO) Earnings and Revenue Records
Mereo Biopharma Group Plc ADR’s EPS increase for this current 12-month fiscal period is 35.71% and is forecasted to reach -0.03 in the upcoming year.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators
Let’s observe the current performance indicators for Mereo Biopharma Group Plc ADR (MREO). It’s Quick Ratio in the last reported quarter now stands at 6.10. The Stock has managed to achieve an average true range (ATR) of 0.15.
Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)
Going through the that latest performance of [Mereo Biopharma Group Plc ADR, MREO]. Its last 5-days volume of 0.97 million was inferior to the volume of 1.24 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 26.23% While, its Average True Range was 0.14.
Raw Stochastic average of Mereo Biopharma Group Plc ADR (MREO) in the period of the previous 100 days is set at 6.69%, which indicates a major fall in contrast to 33.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 53.61% that was lower than 60.24% volatility it exhibited in the past 100-days period.
